Nanotherapy for posterior eye diseases
IP Kaur, S Kakkar - Journal of Controlled Release, 2014 - Elsevier
It is assumed that more than 50% of the most enfeebling ocular diseases have their origin in
the posterior segment. Furthermore, most of these diseases lead to partial or complete …
the posterior segment. Furthermore, most of these diseases lead to partial or complete …
Nanotherapy for posterior eye diseases.
IP Kaur, S Kakkar - Journal of Controlled Release: Official Journal of …, 2014 - europepmc.org
It is assumed that more than 50% of the most enfeebling ocular diseases have their origin in
the posterior segment. Furthermore, most of these diseases lead to partial or complete …
the posterior segment. Furthermore, most of these diseases lead to partial or complete …
Nanotherapy for posterior eye diseases
IP Kaur, S Kakkar - Journal of Controlled Release, 2014 - infona.pl
It is assumed that more than 50% of the most enfeebling ocular diseases have their origin in
the posterior segment. Furthermore, most of these diseases lead to partial or complete …
the posterior segment. Furthermore, most of these diseases lead to partial or complete …
[引用][C] Nanotherapy for posterior eye diseases
IP Kaur, S Kakkar - Journal of Controlled Release, 2014 - cir.nii.ac.jp
Nanotherapy for posterior eye diseases | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
Nanotherapy for posterior eye diseases
IP Kaur, S Kakkar - … of controlled release: official journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
It is assumed that more than 50% of the most enfeebling ocular diseases have their origin in
the posterior segment. Furthermore, most of these diseases lead to partial or complete …
the posterior segment. Furthermore, most of these diseases lead to partial or complete …